Thursday, May 12, 2022 9:06:42 AM
8:30 am ET May 12, 2022 (Globe Newswire) Print
EQNX::TICKER_START (NASDAQ:BWV), EQNX::TICKER_END Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Erin Henderson, Chief Business Officer of Blue Water Vaccines, will present at the H.C. Wainwright Global Investment Conference. The presentation will be available for on-demand webcast viewing starting on Wednesday, May 25, 2022, at 9:00am EDT.
Session details are as follows
Date: Wednesday, May 25, 2022
Time: 9:00am Eastern Daylight Time (EDT)
Title: Blue Water Vaccines Company Presentation
BWV Participant: Erin Henderson, Chief Business Officer
Webcast Link: https://journey.ct.events/view/1e8775a5-ce07-4395-867a-0cadcc5664e5
BWV's management will be available during the conference for one-on-one meetings. Interested parties may request a one-on-one meeting at investors@bluewatervaccines.com or contact BWV at (513) 620-4101.
New York Yankees and Duke Basketball
Recent ONCO News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/03/2024 07:11:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 07:10:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/29/2024 11:38:07 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/01/2024 08:05:12 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 07/22/2024 09:00:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:04:39 AM
- Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds • GlobeNewswire Inc. • 07/15/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:31:06 PM
- Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds • GlobeNewswire Inc. • 07/11/2024 12:17:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/14/2024 09:09:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:35:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:05:48 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:45:43 PM
- Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors • GlobeNewswire Inc. • 02/13/2024 11:00:00 AM
- Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™ • GlobeNewswire Inc. • 12/18/2023 12:00:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM